ClinicalTrials.Veeva

Menu

Kidney Cancer DNA Registry

Memorial Sloan Kettering Cancer Center (MSK) logo

Memorial Sloan Kettering Cancer Center (MSK)

Status

Enrolling

Conditions

Renal Cancer

Treatments

Behavioral: Family History Questionnaire (when applicable)
Behavioral: the Kidney Cancer Questionnaire
Behavioral: Epidemiologic Questionnaire
Other: Blood draw
Other: salvia for germline DNA

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This registry will help us develop better methods of:

  • Preventing these cancers
  • Diagnosing these cancers
  • Treating these cancers

Enrollment

750 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Kidney Cancer Case Cohort:

  • Must be ≥ 18 years of age AND
  • Must be an English-speaker AND
  • Must have a diagnosis or suspicion of kidney cancer

Family Member Cohort:

  • Must be ≥ 18 years of age AND
  • Must be an English-speaker AND
  • Must be a blood relative of the proband. Family members of probands including mother, father, sisters, brothers, half-sisters, half-brothers, daughters, sons, grandmothers, grandfathers, as well as aunts and uncles are eligible. These individuals need not have kidney cancer, as they will be used for segregation analysis of suspected variants found in the proband; requesting DNA from relatives is required.

Control Cohort:

  • Must be ≥ 18 years of age AND
  • Must be an English-speaker AND
  • Must not have a personal history of cancer, with the exception of nonmelanoma skin cancer, AND
  • Must not be a blood relative of any cases or controls enrolled in this study

Exclusion criteria

  • Patients who, in the opinion of the primary MSKCC clinician or the investigator, have a condition that precludes their ability to provide an informed consent

Trial design

750 participants in 4 patient groups

kidney cancer patients receiving care at MSKCC
Description:
Participation will consist of completing the Kidney Cancer Questionnaire Family History Questionnaire and complete the Epidemiologic Questionnaire (when applicable,), and providing a blood sample and saliva sample for germline DNA. In cases where tissue samples from surgically derived tumor specimens are obtained these will used to determine genetic alterations related to cancer predisposition or pathogenicity.
Treatment:
Other: salvia for germline DNA
Other: Blood draw
Behavioral: Epidemiologic Questionnaire
Behavioral: the Kidney Cancer Questionnaire
Behavioral: Family History Questionnaire (when applicable)
relatives of patients with kidney cancer
Description:
Participation will consist of completing the Kidney Cancer Questionnaire Family History Questionnaire (when applicable,), and providing a saliva sample for germline DNA. In cases where tissue samples from surgically derived tumor specimens are obtained these will used to determine genetic alterations related to cancer predisposition or pathogenicity.
Treatment:
Other: salvia for germline DNA
Behavioral: the Kidney Cancer Questionnaire
Behavioral: Family History Questionnaire (when applicable)
healthy controls who are unrelated & do not have hx of cancer
Description:
Participation will consist of completing the Kidney Cancer Questionnaire Family History Questionnaire (when applicable,), and providing a saliva sample for germline DNA. In cases where tissue samples from surgically derived tumor specimens are obtained these will used to determine genetic alterations related to cancer predisposition or pathogenicity.
Treatment:
Other: salvia for germline DNA
Behavioral: the Kidney Cancer Questionnaire
Behavioral: Family History Questionnaire (when applicable)
high risk
Description:
Participation will consist of completing the Epidemiologic Questionnaire, Family History Questionnaire (if + FH), provide saliva and blood sample , referral for screening evaluation
Treatment:
Other: salvia for germline DNA
Other: Blood draw
Behavioral: Epidemiologic Questionnaire
Behavioral: Family History Questionnaire (when applicable)

Trial contacts and locations

7

Loading...

Central trial contact

Jonathan Coleman, MD; Kenneth Offit, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems